Health
SK Bioscience starts developing vaccine against Covid-19 variants – Korea Biomedical Review
SK Bioscience said that it has set about to develop a vaccine to cope with Covid-19 variants with financial support from the Coalition for Epidemic Preparedness…
SK Bioscience said that it has set about to develop a vaccine to cope with Covid-19 variants with financial support from the Coalition for Epidemic Preparedness Innovations (CEPI), an international private organization.
The Korean company will receive up to $14.2 million (about 16 billion won) in research and development funds from CEPI to develop Covid-19 mutants using the development platform of GBP510, for which clinical trials are now underway.
SK Bioscience said it had also received additional…
-
Business19 hours ago1 Australian stock you’ll probably kick yourself for not owning a decade from now
-
Business19 hours agoIs this the best ASX ETF to diversify your portfolio with?
-
Noosa News12 hours agoPeregian Square revitalised | Noosa Today
-
General19 hours agoUsman Khawaja describes Perth Stadium pitch for first Ashes Test as ‘piece of shit’